Takeda Pharmaceutical Company (TAK) Signs a Research Partnership with Nabla Bio
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 14, Reuters reported that Takeda Pharmaceutical Company Limited (NYSE:TAK) and US biotechnology company Nabla Bio signed a major research partnership. The partnership is focused on deepening the use of AI to accelerate drug delivery. This partnership builds on an earlier collaboration, which was launched between the two companies in 2022. As part of this partnership, Nabla will use it ...